BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17827903)

  • 1. Pathologic aspects of intraductal papillary-mucinous neoplasm and pancreatic intraepithelial neoplasia--their associations with carcinogenesis.
    Furukawa T
    Nihon Shokakibyo Gakkai Zasshi; 2007 Sep; 104(9):1329-37. PubMed ID: 17827903
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm?
    Klöppel G; Kosmahl M
    J Hepatol; 2006 Feb; 44(2):249-50. PubMed ID: 16360969
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
    Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A
    Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of Pancreatic Cancer Precursor Lesions.
    Noë M; Brosens LA
    Surg Pathol Clin; 2016 Dec; 9(4):561-580. PubMed ID: 27926360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasia.
    McGrath KM; Krasinskas AM; Federle MP
    Gastroenterol Clin North Am; 2007 Jun; 36(2):377-90, ix-x. PubMed ID: 17533085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morules in intraductal papillary mucinous neoplasm with an associated invasive carcinoma of the pancreas.
    Tateno Y; Esaki M; Shimada K; Ojima H; Kanai Y; Hiraoka N
    Pancreas; 2012 May; 41(4):651-2. PubMed ID: 22504383
    [No Abstract]   [Full Text] [Related]  

  • 8. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas.
    Pittman ME; Rao R; Hruban RH
    Arch Pathol Lab Med; 2017 Dec; 141(12):1606-1614. PubMed ID: 29189063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis.
    Hiraoka N; Yamazaki-Itoh R; Ino Y; Mizuguchi Y; Yamada T; Hirohashi S; Kanai Y
    Gastroenterology; 2011 Jan; 140(1):310-21. PubMed ID: 20955708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary mucinous neoplasms of the pancreas: pathology and molecular genetics.
    Adsay NV
    J Gastrointest Surg; 2002; 6(5):656-9. PubMed ID: 12399051
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm".
    Matsuda R; Miyasaka Y; Yamada Y; Kawata J; Sakihama K; Yamamoto T; Saeki K; Yamamoto H; Ohishi Y; Koga Y; Nakamura M; Oda Y
    Virchows Arch; 2020 Dec; 477(6):799-806. PubMed ID: 32468246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
    Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F
    Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of invasive intraductal papillary mucinous neoplasm.
    Longnecker DS; Klöppel G
    Pancreas; 2008 Oct; 37(3):333; author reply 333-4. PubMed ID: 18815559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Precursors of Pancreatic cancer: Intraepithelial Neoplasia (PanIN) and Intraductal Papillary Mucinous Neoplasms (IPMN)].
    Ledniczky G; Bognár G; Bereczky B; Barabás L; Ondrejka P
    Magy Seb; 2009 Feb; 62(1):22-6. PubMed ID: 19218165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraductal papillary-mucinous neoplasm of the pancreas].
    Yamaguchi K; Watanabe M; Nakamura M; Konomi H; Tanaka M
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():52-9. PubMed ID: 16457221
    [No Abstract]   [Full Text] [Related]  

  • 18. A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
    Ghaneh P; Neoptolemos J
    Gut; 2007 Aug; 56(8):1041-4. PubMed ID: 17625140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precursors to invasive pancreatic cancer.
    Maitra A; Fukushima N; Takaori K; Hruban RH
    Adv Anat Pathol; 2005 Mar; 12(2):81-91. PubMed ID: 15731576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare Brain Metastasis From a Pancreatobiliary Subtype of Intraductal Papillary Mucinous Neoplasm.
    Arao Y; Kamimura K; Ikemi M; Hayashi K; Takaki M; Takahashi S; Seino S; Abe H; Tsuboguchi S; Otsu Y; Sanpei K; Kohisa J; Kondo S; Tani Y; Ito J; Toyoshima Y; Kakita A; Ajioka Y; Terai S
    Pancreas; 2020 Jan; 49(1):e8-e11. PubMed ID: 31856097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.